Improving Coping to Reduce Suicide Risk Following ED Discharge
Launched by UNIVERSITY OF MICHIGAN · Sep 25, 2024
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at new ways to help adults who have recently experienced suicidal thoughts or behaviors after leaving the emergency department (ED). The researchers want to see if an electronic safety plan (ESP), which is a personalized guide for staying safe, along with a supportive text messaging program, can help these individuals cope better and reduce their risk of suicide. By testing these tools, they hope to find effective ways to support patients after their ED visit.
To be eligible for this study, participants need to be adults who have either attempted suicide in the last month or have had thoughts of harming themselves in the past week. However, the study will not include individuals who are severely mentally impaired, very aggressive, or who are being admitted to a hospital for more treatment. Participants can expect to engage with the ESP and receive supportive messages on their phones, which will help them manage their feelings and stay safe after their emergency visit. This trial is not yet recruiting participants, but it is an important step toward improving care for people at risk of suicide.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- Individuals presenting to an ED with either:
- • 1. actual, interrupted, or aborted attempt in the last 4 weeks
- • 2. suicidal ideation within the last week
- Exclusion Criteria:
- • Severe cognitive impairment or altered mental status (psychosis, manic state)
- • Severe aggression/agitation,
- • Being admitted or transferred into inpatient care,
- • Patient not owning a cell phone with text messaging capability
About University Of Michigan
The University of Michigan, a leading academic institution renowned for its commitment to advancing healthcare and medical research, serves as a prominent clinical trial sponsor. With a robust infrastructure that supports innovative research initiatives, the university leverages its multidisciplinary expertise to conduct a wide array of clinical trials aimed at improving patient outcomes and advancing medical knowledge. Through its state-of-the-art facilities and collaborative environment, the University of Michigan fosters partnerships between researchers, clinicians, and industry leaders, ensuring the development of cutting-edge therapies and interventions that address pressing health challenges.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ann Arbor, Michigan, United States
Patients applied
Trial Officials
Ewa Czyz, Ph.D.
Principal Investigator
University of Michigan
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported